Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/L-371,257> ?p ?o }
Showing triples 1 to 70 of
70
with 100 triples per page.
- L-371,257 abstract "L-371,257 is a compound used in scientific research which acts as a selective antagonist of the oxytocin receptor with over 800x selectivity over the related vasopressin receptors. It was one of the first non-peptide oxytocin antagonists developed, and has good oral bioavailability, but poor penetration of the blood–brain barrier, which gives it good peripheral selectivity with few central side effects. Potential applications are likely to be in the treatment of premature labour.".
- L-371,257 casNumber "162042-44-6".
- L-371,257 iupacName "1-[4-[(1-Acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]-4-(2-oxo-2H-3,1-benzoxazin-1(4H)-yl)piperidine".
- L-371,257 pubchem "6918320".
- L-371,257 thumbnail L-371,257_structure.png?width=300.
- L-371,257 wikiPageID "22376382".
- L-371,257 wikiPageLength "8071".
- L-371,257 wikiPageOutDegree "12".
- L-371,257 wikiPageRevisionID "706834226".
- L-371,257 wikiPageWikiLink Atosiban.
- L-371,257 wikiPageWikiLink Barusiban.
- L-371,257 wikiPageWikiLink Blood–brain_barrier.
- L-371,257 wikiPageWikiLink Category:Oxytocin_receptor_antagonists.
- L-371,257 wikiPageWikiLink Category:Peripherally_selective_drugs.
- L-371,257 wikiPageWikiLink Category:Tocolytics.
- L-371,257 wikiPageWikiLink Epelsiban.
- L-371,257 wikiPageWikiLink L-368,899.
- L-371,257 wikiPageWikiLink Oxytocin_receptor.
- L-371,257 wikiPageWikiLink Receptor_antagonist.
- L-371,257 wikiPageWikiLink Retosiban.
- L-371,257 wikiPageWikiLink Vasopressin_receptor.
- L-371,257 wikiPageWikiLinkText "L-371,257".
- L-371,257 c "28".
- L-371,257 casNumber "162042".
- L-371,257 chembl "24781".
- L-371,257 chemspiderid "5293524".
- L-371,257 h "33".
- L-371,257 inchi "1".
- L-371,257 inchikey "WDERJSQJYIJOPD-UHFFFAOYAI".
- L-371,257 iupacName "1".
- L-371,257 iupharLigand "2252".
- L-371,257 molecularWeight "507.577".
- L-371,257 n "3".
- L-371,257 o "6".
- L-371,257 pubchem "6918320".
- L-371,257 smiles "O=C1OCc3ccccc3N1CCCN4Cc2cccOC5CCNCC5".
- L-371,257 stdinchi "1".
- L-371,257 stdinchikey "WDERJSQJYIJOPD-UHFFFAOYSA-N".
- L-371,257 verifiedfields "changed".
- L-371,257 verifiedrevid "444650848".
- L-371,257 wikiPageUsesTemplate Template:Cascite.
- L-371,257 wikiPageUsesTemplate Template:Chemspidercite.
- L-371,257 wikiPageUsesTemplate Template:Drugbankcite.
- L-371,257 wikiPageUsesTemplate Template:Drugbox.
- L-371,257 wikiPageUsesTemplate Template:Ebicite.
- L-371,257 wikiPageUsesTemplate Template:Neuropeptidergics.
- L-371,257 wikiPageUsesTemplate Template:Reflist.
- L-371,257 wikiPageUsesTemplate Template:Stdinchicite.
- L-371,257 subject Category:Oxytocin_receptor_antagonists.
- L-371,257 subject Category:Peripherally_selective_drugs.
- L-371,257 subject Category:Tocolytics.
- L-371,257 hypernym Compound.
- L-371,257 type ChemicalCompound.
- L-371,257 type ChemicalSubstance.
- L-371,257 type Drug.
- L-371,257 type Chemical.
- L-371,257 type Drug.
- L-371,257 type ChemicalObject.
- L-371,257 type Thing.
- L-371,257 type Q8386.
- L-371,257 comment "L-371,257 is a compound used in scientific research which acts as a selective antagonist of the oxytocin receptor with over 800x selectivity over the related vasopressin receptors. It was one of the first non-peptide oxytocin antagonists developed, and has good oral bioavailability, but poor penetration of the blood–brain barrier, which gives it good peripheral selectivity with few central side effects. Potential applications are likely to be in the treatment of premature labour.".
- L-371,257 label "L-371,257".
- L-371,257 sameAs Q6456065.
- L-371,257 sameAs m.05szvfg.
- L-371,257 sameAs L-371,257.
- L-371,257 sameAs L-371,257.
- L-371,257 sameAs Q6456065.
- L-371,257 wasDerivedFrom L-371,257?oldid=706834226.
- L-371,257 depiction L-371,257_structure.png.
- L-371,257 isPrimaryTopicOf L-371,257.